Researchers examine how the use of animal testing to identify endocrine-disrupting substances in the EU can be reduced.

LONDON, GREATER LONDON, UNITED KINGDOM, June 19, 2025 /EINPresswire.com/ -- The pharmaceutical manufacturing market size has grown rapidly in recent years. It substantially expanded from $519.78 ...

Also Read: AbbVie To Present Cancer Trial Data At Upcoming ASCO Event With this approval, Mavyret is the first and only DAA therapy approved to treat patients with acute HCV in eight weeks with a ...

The Bombay High Court on Tuesday (June 3, 2025) allowed animal sacrifice during Id and Urs (death anniversary of a Sufi saint) celebrations at a dargah located within the precincts of the ...

Wildlife researchers train AI to better identify animal species in trail camera photos by Steve Lundeberg, Oregon State University edited by Gaby Clark, reviewed by Robert Egan Editors' notes ...

The Animal Identification and Traceability (ANITRAC) system has been officially unveiled, paving the way for its trial phase ahead of the long-anticipated national rollout.

India News: Despite conclusive proof of Abbvie sponsoring foreign tours for 30 doctors, violating marketing practices, the National Medical Commission claims to l ...

--AbbVie today announced submission of a Biologics License Application to the U.S. Food and Drug Administration for trenibotulinumtoxinE for the treatment of moderate to severe glabellar lines.

AbbVie (NYSE:ABBV) is scheduled to announce its earnings on Friday, April 25, 2025. Currently, the company holds a market capitalization of $307 billion. Over the past twelve months, AbbVie ...

Today, AbbVie's stock sits roughly 20% off its highs. It's a good time to take a breather, assess the underlying business, and consider whether the stock's decline offers enough value to make ...

AbbVie discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers: Humira, an injection for autoimmune and intestinal Behçet’s diseases and pyoderma gangrenosum ...